Ludgate Kristen M
Known title: DirectorCIK: 0001727434
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HPQ earnings beat followed by stock decline. HP reported earnings that exceeded analysts' expectations, marking a positive surprise for the quarter. Despite the beat, the shares fell more than the broader market, drawing fresh attention to the stock's recent weakness. The price is now near a long‑standing support level around $24.05, a point that has been tested many times.
Transaction History
| ASB | ▲ Buy | Grant | 36 | $1K | 9/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 38 | $1K | 6/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 44 | $1K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 4,585 | $125K | 2/1/2026 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 9/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 50 | $1K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 51 | $1K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 4,972 | $125K | 2/1/2025 | View on chart |
| HPQ | ▼ Sell | Open Market | 74,356 | $2.6M | 12/13/2024 | View on chart |
| ASB | ▲ Buy | Grant | 255 | $7K | 12/11/2024 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 21,184 | $767K | 12/7/2024 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 46,453 | $0 | 12/7/2024 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 11,367 | $0 | 11/20/2024 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 5,184 | $190K | 11/20/2024 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 87,994 | $0 | 7/12/2024 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 45,090 | $1.7M | 7/12/2024 | View on chart |
| HPQ | ▼ Sell | Open Market | 41,015 | $1.2M | 3/5/2024 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 15,937 | $469K | 12/7/2023 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 28,539 | $0 | 12/7/2023 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 85,079 | $0 | 7/12/2023 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 46,721 | $1.5M | 7/12/2023 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 6,588 | $183K | 12/7/2022 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 11,797 | $0 | 12/7/2022 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 82,167 | $0 | 7/12/2022 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 41,152 | $1.3M | 7/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.